Found: 64
Select item for more details and to access through your institution.
Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells.
- Published in:
- Clinical & Experimental Immunology, 2024, v. 217, n. 3, p. 233, doi. 10.1093/cei/uxae051
- By:
- Publication type:
- Article
Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?
- Published in:
- Calcified Tissue International, 2024, v. 114, n. 2, p. 98, doi. 10.1007/s00223-023-01155-3
- By:
- Publication type:
- Article
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 370, doi. 10.1159/000515551
- By:
- Publication type:
- Article
From an understanding of etiopathogenesis to novel therapies--what is new in the treatment of celiac disease?
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1378172
- By:
- Publication type:
- Article
Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods.
- Published in:
- Nutrients, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/nu14142942
- By:
- Publication type:
- Article
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 12, p. 2493, doi. 10.3390/nu14122493
- By:
- Publication type:
- Article
Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?
- Published in:
- Nutrients, 2022, v. 14, n. 6, p. 1223, doi. 10.3390/nu14061223
- By:
- Publication type:
- Article
Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis.
- Published in:
- Nutrients, 2018, v. 10, n. 12, p. 1940, doi. 10.3390/nu10121940
- By:
- Publication type:
- Article
Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 9, p. 1, doi. 10.5812/hepatmon.11721
- By:
- Publication type:
- Article
Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 2, p. 240, doi. 10.1177/1756283X15618129
- By:
- Publication type:
- Article
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients.
- Published in:
- QJM: An International Journal of Medicine, 2008, v. 101, n. 6, p. 505, doi. 10.1093/qjmed/hcn016
- By:
- Publication type:
- Article
A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival.
- Published in:
- Gastroenterology Insights, 2023, v. 14, n. 1, p. 38, doi. 10.3390/gastroent14010005
- By:
- Publication type:
- Article
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib.
- Published in:
- Internal & Emergency Medicine, 2024, v. 19, n. 4, p. 1151, doi. 10.1007/s11739-024-03578-8
- By:
- Publication type:
- Article
Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective.
- Published in:
- Internal & Emergency Medicine, 2023, v. 18, n. 5, p. 1405, doi. 10.1007/s11739-023-03307-7
- By:
- Publication type:
- Article
COVID-19: Has the Liver Been Spared?
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1091, doi. 10.3390/ijms24021091
- By:
- Publication type:
- Article
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials.
- Published in:
- Liver International, 2022, v. 42, n. 2, p. 458, doi. 10.1111/liv.15117
- By:
- Publication type:
- Article
Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 529, doi. 10.1111/liv.14778
- By:
- Publication type:
- Article
International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis.
- Published in:
- Liver International, 2020, v. 40, n. 6, p. 1467, doi. 10.1111/liv.14436
- By:
- Publication type:
- Article
The evolutionary scenario of hepatocellular carcinoma in Italy: an update.
- Published in:
- Liver International, 2017, v. 37, n. 2, p. 259, doi. 10.1111/liv.13204
- By:
- Publication type:
- Article
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
- Published in:
- Current Oncology, 2024, v. 31, n. 1, p. 547, doi. 10.3390/curroncol31010038
- By:
- Publication type:
- Article
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis.
- Published in:
- Current Oncology, 2023, v. 30, n. 3, p. 2613, doi. 10.3390/curroncol30030199
- By:
- Publication type:
- Article
Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up.
- Published in:
- Digestive Diseases & Sciences, 2008, v. 53, n. 6, p. 1582, doi. 10.1007/s10620-007-0058-0
- By:
- Publication type:
- Article
Editorial: gut microbiota profile in patients with autoimmune hepatitis—a clue for adjunctive probiotic therapy?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 392, doi. 10.1111/apt.15795
- By:
- Publication type:
- Article
PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2010, v. 105, n. 1, p. 125, doi. 10.1038/ajg.2009.596
- By:
- Publication type:
- Article
The Serological Profile of the Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2009, v. 104, n. 6, p. 1420, doi. 10.1038/ajg.2009.126
- By:
- Publication type:
- Article
Natural Course of Chronic HCV and HBV Infection and Role of Alcohol in the General Population: The Dionysos Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 9, p. 2248, doi. 10.1111/j.1572-0241.2008.01948.x
- By:
- Publication type:
- Article
LKM1-Positive Type 2 Autoimmune Hepatitis Following Allogenic Hematopoietic Stem-Cell Transplantation.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Antitransglutaminase Antibodies and Giardiasis.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
Celiac disease in autoimmune cholestatic liver disorders
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2002, v. 97, n. 10, p. 2609, doi. 10.1111/j.1572-0241.2002.06031.x
- By:
- Publication type:
- Article
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 403, doi. 10.1007/s00432-017-2556-6
- By:
- Publication type:
- Article
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 834, doi. 10.3390/diagnostics12040834
- By:
- Publication type:
- Article
Coeliac Disease in Patients with Autoimmune Thyroiditis.
- Published in:
- Digestion, 2001, v. 64, n. 1, p. 61, doi. 10.1159/000048840
- By:
- Publication type:
- Article
Clinical Impact of Non-Organ-Specific Autoantibodies on the Response to Combined Antiviral Treatment in Patients with Hepatitis C.
- Published in:
- Clinical Infectious Diseases, 2005, v. 40, n. 4, p. 501, doi. 10.1086/427285
- By:
- Publication type:
- Article
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232449
- By:
- Publication type:
- Article
Anti-ganglioside antibodies and celiac disease.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 1, p. e65, doi. 10.5301/jbm.5000117
- By:
- Publication type:
- Article
Nailfold Capillaroscopy in Primary Biliary Cirrhosis: a Useful Tool for the Early Diagnosis of Scleroderma.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2014, v. 23, n. 1, p. 39, doi. 10.15403/jgld-1277
- By:
- Publication type:
- Article
Experience with regorafenib in the treatment of hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211016959
- By:
- Publication type:
- Article
Experience with regorafenib in the treatment of hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211016959
- By:
- Publication type:
- Article
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1080, doi. 10.3390/cancers16061080
- By:
- Publication type:
- Article
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1523, doi. 10.3390/cancers15051523
- By:
- Publication type:
- Article
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 381, doi. 10.3390/cancers15020381
- By:
- Publication type:
- Article
Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5).
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 336, doi. 10.3390/cancers14020336
- By:
- Publication type:
- Article
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6376, doi. 10.3390/cancers13246376
- By:
- Publication type:
- Article
From Liver Fat to Cancer: Perils of the Western Diet.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1095, doi. 10.3390/cancers13051095
- By:
- Publication type:
- Article
Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 842, doi. 10.3390/cancers13040842
- By:
- Publication type:
- Article
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3182, doi. 10.3390/cancers12113182
- By:
- Publication type:
- Article
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
- Published in:
- Liver International, 2015, v. 35, n. 3, p. 1036, doi. 10.1111/liv.12574
- By:
- Publication type:
- Article